{
    "accession": "ENCBS272IFK",
    "age": "21",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "CL:0000906",
    "biosample_term_name": "activated CD8-positive, alpha-beta T cell",
    "biosample_type": "primary cell",
    "characterizations": [],
    "dbxrefs": [
        "GEO:SAMN22786071"
    ],
    "description": "",
    "documents": [
        {
            "attachment": "/documents/eb624ae4-53ea-4de0-ba9e-11b40eb20e2c/@@download/attachment/ENCODE-Methods%2011.14.22.pdf",
            "document_type": "cell isolation protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO781BMZ",
    "lab": "Yijun Ruan, JAX",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "AllCells",
    "summary": "Homo sapiens male adult (21 years) activated CD8-positive, alpha-beta T primary cell treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 5,
            "duration_units": "day",
            "treatment_term_id": "UniProtKB:P60568",
            "treatment_term_name": "Interleukin-2",
            "treatment_type": "protein"
        },
        {
            "dbxrefs": [],
            "duration": 7,
            "duration_units": "day",
            "treatment_term_name": "anti-CD3 and anti-CD28 coated beads",
            "treatment_type": "antibody"
        }
    ]
}